| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000028410 |
| Receipt No. | R000031533 |
| Scientific Title | Study of various clinical parameters and retinal thickness by optical coherence tomography (OCT) in patients with diabetes mellitus. |
| Date of disclosure of the study information | 2017/08/01 |
| Last modified on | 2020/08/03 (Ver. 3) |
| Basic information | ||
| Public title | Study of various clinical parameters and retinal thickness by optical coherence tomography (OCT) in patients with diabetes mellitus. | |
| Acronym | Retinal Thickness and Clinical Parameters | |
| Scientific Title | Study of various clinical parameters and retinal thickness by optical coherence tomography (OCT) in patients with diabetes mellitus. | |
| Scientific Title:Acronym | Retinal Thickness and Clinical Parameters | |
| Region |
|
|
| Condition | |||
| Condition | Type 2 diabetes | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | In order to evaluate the pathology of diabetic macular edema in diabetic patients and establish a novel treatment method, evaluation of blood sugar control status, evaluation of retinal edema by optical coherence tomography (OCT), evaluation of retinal blood flow by OCT angiography, plasma aldosterone concentration And other biochemical parameters are evaluated as main evaluation items. |
| Basic objectives2 | Others |
| Basic objectives -Others | association |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Retinal change due to OCT by glycemic control an plasma aldosterone concentration. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Blood sampling at discharge
Optical coherence tomography at hospitalization and discharge |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Type 2 diabetic patients who were hospitalized during the study period. | |||
| Key exclusion criteria | Patients with have undergone laser photocoagulation.
Cataracts in progress. Minors. Those who are difficult to determine consciousness by themselves, such as consciousness disorder or dementia. Those in steroid treatment. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | The Jikei university school of medicine. Katsushika medical center | ||||||
| Division name | division of diabetes metabolism and endocrinology | ||||||
| Zip code | 105-8471 | ||||||
| Address | 6-41-2 aoto, katsushika-ku, tokyo, japan | ||||||
| TEL | 03-3603-2111 | ||||||
| takeshihayashi@jikei.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | The Jikei university school of medicine. Katsushika medical center | ||||||
| Division name | division of diabetes metabolism and endocrinology | ||||||
| Zip code | 125-8506 | ||||||
| Address | 6-41-2 aoto, katsushika-ku, tokyo, japan | ||||||
| TEL | 03-3603-2111 | ||||||
| Homepage URL | |||||||
| takeshihayashi@jikei.ac.jp | |||||||
| Sponsor | |
| Institute | The Jikei university school of medicine. Katsushika medical center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Jikei university school of medicine. Katsushika medical center |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Jikei university school of medicine. |
| Address | 6-41-2 aoto, katsushika-ku, tokyo, japan |
| Tel | 03-3603-2111 |
| takeshihayashi@jikei.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031533 |